enterocin has been researched along with pediocin pa-1 in 2 studies
| Studies (enterocin) | Trials (enterocin) | Recent Studies (post-2010) (enterocin) | Studies (pediocin pa-1) | Trials (pediocin pa-1) | Recent Studies (post-2010) (pediocin pa-1) |
|---|---|---|---|---|---|
| 136 | 0 | 81 | 122 | 0 | 34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavera, VL; Chikindas, ML; Sutyak Noll, K; Tiwari, SK | 1 |
| Buss, GP; Wilson, CM | 1 |
2 other study(ies) available for enterocin and pediocin pa-1
| Article | Year |
|---|---|
Improved antimicrobial activities of synthetic-hybrid bacteriocins designed from enterocin E50-52 and pediocin PA-1.
Topics: Anti-Bacterial Agents; Bacteriocins; Bridged-Ring Compounds; Escherichia coli O157; Microbial Sensitivity Tests; Micrococcus luteus; Pediocins; Recombinant Fusion Proteins; Salmonella enteritidis | 2015 |
Exploring the cytotoxic mechanisms of Pediocin PA-1 towards HeLa and HT29 cells by comparison to known bacteriocins: Microcin E492, enterocin heterodimer and Divercin V41.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Apoptosis; Bacteriocins; Bridged-Ring Compounds; Cell Survival; COVID-19; HeLa Cells; HT29 Cells; Humans; Models, Molecular; Pandemics; Pediocins; Protein Conformation; SARS-CoV-2; Sequence Homology, Amino Acid; Toll-Like Receptor 4 | 2021 |